Home | Welcome to Contract Pharma   
Last Updated Monday, November 24 2014
Print

Trials & Filings in Brief: Nov. 20, 2013



By Gil Roth



Published November 20, 2013
Phase II
Advaxis starts HPV cancer trial . . . read more

Amgen presents PCSK9 LDL results . . . read more

CytRx starts GBM trial . . . read more

Zealand begins danegaptide POC trial . . . read more

Phase III
Daiichi's edoxaban exceeds warfarin targets . . . read more

Filings
Health Canada approves Sanofi's Aubagio . . . read more

Launches
Cornerstone launches Bethkis for CF . . . read more


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On